Allworth Financial’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Allworth Financial's HAE Position: Q2 2026 in Review
Allworth Financial increased its Haemonetics (HAE) stake by 2.9% in Q2 2026, buying an estimated $1.41K and bringing the position to 782 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.
Allworth Financial first reported a position in HAE in Q1 2022 and has held it in 18 quarters since. The position peaked at $111K in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Allworth Financial held 782 shares of Haemonetics worth $58.6K as of Q2 2026.
- Allworth Financial bought 22 Haemonetics shares in Q2 2026, an estimated $1.41K.
- Haemonetics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2343 holding.
- Allworth Financial first reported a position in Haemonetics in Q1 2022 and has held it in 18 quarters since.
- Allworth Financial's Haemonetics position peaked at $111K in Q2 2024.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.